Literature DB >> 6732228

Effects of furosemide, piretanide, and water loading on urinary excretion of cefazolin in humans.

C Morgant, A Contrepois, N P Chau, A Romaru, J B Fourtillan, C Carbon.   

Abstract

Antibiotics and diuretics are often prescribed concomitantly for humans. We compared the effects of two potent loop diuretics, furosemide and piretanide, with those of water loading on the urinary excretion of cefazolin. During a continuous infusion of inulin and cefazolin (10 mg/kg per h), six healthy male volunteers received a single intravenous injection of furosemide (0.3 mg/kg) or piretanide (0.1 mg/kg) or again an oral water load of 15 ml/kg over a 20-min period. In vitro, furosemide at all concentrations tested significantly reduced by about 10% the percentage of cefazolin bound to serum proteins. Piretanide exhibited such an effect only at a concentration of 2 micrograms/ml. Furosemide, piretanide, and water loading significantly and similarly increased the ratio of excreted to infused cefazolin up to 2 h after the injection of diuretic or after oral water intake. In each of the three parts of the experiment, the increase of the urinary flow rate was similar when compared with the control values. Furosemide significantly increased the cefazolin filtered load during the same time. Piretanide significantly enhanced the absolute rate of net cefazolin tubular secretion. Water loading increased the urinary excretion of cefazolin, probably through a reduction in tubular reabsorption. These results suggest that (i) furosemide and piretanide as well as water loading are capable of enhancing renal excretion of cefazolin by different complex mechanisms; (ii) cefazolin undergoes a bidirectional tubular transport; (iii) piretanide might act on the proximal tubule in addition to its main site of action on Henle's loop; and (iv) the effects of both diuretics and of water loading are unlikely to affect in vivo antibiotic activity in humans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6732228      PMCID: PMC185599          DOI: 10.1128/AAC.25.5.618

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Effect of diuretics on urinary excretion of cephalothin in humans.

Authors:  A D Tice; M Barza; M G Bergeron; J L Brusch; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

3.  Effects of furosemide on glomerular filtration rate and clearance of practolol, digoxin, cephaloridine, and gentamicin.

Authors:  W J Tilstone; P F Semple; D H Lawson; J A Boyle
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

4.  Standardization of a preparative ultracentrifuge method for quantitative determination or protein binding of seven antibiotics.

Authors:  L R Peterson; W H Hall; H H Zinneman; D N Gerding
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

5.  Kinetic and dynamic comparison of piretanide and furosemide.

Authors:  J R Lawrence; A F Ansari; H L Elliott; D J Sumner; G F Brunton; B Whiting; R Whitesmith
Journal:  Clin Pharmacol Ther       Date:  1978-05       Impact factor: 6.875

6.  Determination of cephalosporins in biological material by reversed-phase liquid column chromatography.

Authors:  A M Brisson; J B Fourtillan
Journal:  J Chromatogr       Date:  1981-05-08

7.  Interaction between cephaloridine and furosemide in man.

Authors:  R Norrby; K Stenqvist; B Elgefors
Journal:  Scand J Infect Dis       Date:  1976

8.  Effects of phenylbutazone on extravascular diffusion, protein binding and urinary excretion of cefazolin in rabbits.

Authors:  C Carbon; A Contrepois; Y Nivoche; M Grandjean; S Decourt; N P Chau
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

9.  Furosemide kinetics in renal failure.

Authors:  W J Tilstone; A Fine
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875

10.  Effects of furosemide on extravascular diffusion, protein binding and urinary excretion of cephalosporins and aminoglycosides in rabbits.

Authors:  C Carbon; A Contrepois; A M Vigneron; S Lamotte-Barrillon
Journal:  J Pharmacol Exp Ther       Date:  1980-06       Impact factor: 4.030

View more
  4 in total

1.  Protein binding of cefazolin is saturable in vivo both between and within patients.

Authors:  Jane W A Vella-Brincat; Evan J Begg; Carl M J Kirkpatrick; Mei Zhang; Stephen T Chambers; Kate Gallagher
Journal:  Br J Clin Pharmacol       Date:  2007-01-12       Impact factor: 4.335

Review 2.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

3.  Alteration of gentamicin and cefazolin kinetics with control of the hypothyroid state in humans.

Authors:  P Chanson; V Joly; A Contrepois; J J Garaud; J Bauchet; J Mohler; P C Nguyen; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 4.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.